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Recently the introduction of time-resolved spectroscopy in conjunction with diffusion theory has led to quantitative tissue spectroscopy and absolute tissue oximetry. 2, 3 Optical tissue oximetry measures the hemoglobin saturation in tissue ͑Y ͒, and it is most sensitive to the blood in the capillaries, 4 where oxygen exchange with tissue occurs.
Optical spectroscopy can also be used to measure the saturation of arterial blood ͑SaO 2 ͒. The hemoglobin concentration in tissue oscillates with time as a result of the arterial pulsation associated with the systolic -diastolic pressure variation. 5 Consequently the detected oscillations in the optical signal can be attributed to the arterial blood, whose saturation is then related to the oscillatory components of the optical densities at two or more wavelengths. On the basis of this principle, pulse oximetry was introduced in 1974 6 and entered clinical practice in the 1980's. The pulse oximeter, which is usually applied to a finger, toe, nose, or earlobe, gives an SaO 2 reading on the basis of an empirical scaling based on a preliminary calibration on a population of reference subjects. 7 Such empirical scaling causes inaccurate readings in the low ͑,80%͒ and the high ͑.97%͒ saturation limits. 8 Furthermore, the SaO 2 saturation measured in a finger or a toe may not be representative of the systemic arterial saturation.
In this Letter we present a novel approach to absolute oximetry that yields simultaneous absolute measurements of Y and SaO 2 , noninvasively and in real time. We have applied this novel technique to absolute measurements of local saturation in the brain, even though it can be applied to other tissues as well. Our approach does not require any preliminary calibration (not even an instrument calibration), nor does it use an empirical lookup table based on data from a reference subject population.
Our frequency-domain tissue spectrometer (see Fig. 1 sources is therefore 224 ms. We group the two sets of eight fibers (each 400 mm in core diameter) that guide the light at the eight wavelengths into two fiber bundles (source fibers). The optical signal detected at the tissue surface is guided to the two parallel detector channels of the spectrometer by two optical fiber bundles, each 3 mm in internal diameter (detector fibers). The source and the detector fibers are placed on the same side of the examined tissue (the forehead in this case) in the symmetrical conf iguration shown in Fig. 1 . This geometric arrangement, first described by Hueber et al., features two distinct source -detector separations (3.0 and 3.6 cm) and provides quantitative spectroscopy that is independent of source, detector, and optical-coupling terms, i.e., without requiring any sort of instrumental calibration. 10 Absolute tissue oximetry requires measurement of the absolute absorption spectrum of the tissue. We performed absolute tissue spectroscopy, using the multidistance frequency-domain method, assuming a homogeneous and semi-infinite geometry. 11 The absolute values of the absorption ͑m a ͒ and the reduced scattering ͑m s 0 ͒ coeff icients of the tissue are given in terms of the dc and the phase slopes versus sourcedetector separation (S dc and S F , respectively).
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To maximize the signal-to-noise ratio we updated the calculation of m s 0 every 10 s. In this fashion we signif icantly reduced the contribution of the phase noise to the measurement of m a , while keeping the 224-ms acquisition time for the absorption spectrum.
Absolute pulse oximetry requires quantitative measurement of the amplitude of arterial-pulsationinduced absorption oscillations. The absorption oscillations ͑Dm a ͒ can be effectively measured from the variations in the average intensity at each sourcedetector pair, by use of the differential path-length factor (DPF) method. 12 The DPF method requires knowledge of the average photon path length in the tissue and, most importantly, of its wavelength dependence. Since assuming a wrong wavelength dependence of the DPF can lead to significant errors in the value of SaO 2 , we have taken advantage of the frequency-domain data to measure the DPF spectrum, rather than relying on DPF spectra reported in the literature. We evaluated the amplitude of the arterial-pulsation-induced absorption variations by taking the sum of the amplitudes of the fast Fourier transform of Dm a over the heartbeat band. We evaluated the fast Fourier transform of Dm a over 64 points, corresponding to a time trace 14.3 s long, to achieve reliable and reproducible spectra from a number of heartbeat periods. We verif ied that the absorption oscillations at the eight wavelengths were in phase.
We stress that frequency-domain data are of crucial importance in our approach to absolute tissue and pulse oximetry. In fact, we used both the intensity and the phase data to measure the reduced scattering coeff icient of the tissue (in the determination of Y ) and the spectrum of the DPF (in the determination of SaO 2 ). To measure the hemoglobin saturation we fitted the absorption spectra with a linear combination of the extinction spectra of oxy-hemoglobin (e HbO2 ) and deoxy-hemoglobin (e Hb ). The fitted parameters are the concentrations of oxy-hemoglobin (͓HbO 2 ͔) and deoxy-hemoglobin ([Hb]). The hemoglobin saturation is then given by the expression ͓HbO 2 ͔͓͑͞HbO 2 ͔ 1 ͓Hb͔͒.
To achieve a variation in the arterial and the cerebral saturation we performed a measurement protocol involving a change in the oxygen concentration inspired by the subject. A healthy volunteer breathed a 21% oxygen concentration (by volume; room air) for 1 min; then the inspired oxygen concentration was lowered to 10% (by volume) for 1 min, and finally it was brought back to 21%. This protocol was approved by the Institutional Review Board of the University of Illinois at Urbana -Champaign. Simultaneously with the measurement from the forehead with our frequency-domain spectrometer, we monitored SaO 2 with a commercial pulse oximeter (Nellcor N-200) attached to the index finger of the subject.
The absolute absorption spectra and the spectra of the amplitude of the absorption oscillations at the heartbeat frequency are shown in Fig. 2 under baseline conditions (21% inspired oxygen) and at maximal desaturation induced by 1 min of 10% inspired oxygen concentration. In Table 1 we report the values of Y and SaO 2 obtained from the fits of Fig. 2 , and we compare them with the corresponding values of SaO 2 provided by the commercial pulse oximeter. In Fig. 3 we show the time traces of Y and SaO 2 recorded on line during the experiment. The values of SaO 2 measured with our absolute spectroscopic method and with the commercial pulse oximeter were in excellent agreement throughout the experiment.
We have presented a frequency-domain approach to noninvasive measurement of the absolute values of Fig. 2 . Effect of the reduced inspired oxygen concentration [1 min of 10% (by volume) O 2 from a baseline value of 21%] on the tissue absorption spectrum (tissue m a ) and on the spectrum of the amplitude of the pulsed absorption component at the heartbeat frequency (arterial Dm a ). The symbols are the experimental data measured from the forehead, and the curves are the best fits of the data with a linear combination of the extinction spectra of HbO 2 and Hb. The saturation values corresponding to the four fitted spectra are reported in Table 1 . a The f irst row refers to a baseline condition of 21% (by volume) inspired oxygen concentration, whereas the second row refers to the maximal desaturation condition after the inspired oxygen concentration was decreased to 10% for 1 min. local Y and SaO 2 simultaneously and in real time.
The good fits obtained with the eight wavelengths that were used (Fig. 2) conf irm that Hb and HbO 2 are the major species that contribute to the absorption spectra. Therefore two wavelengths may be suff icient for measuring absolute Y and SaO 2 . With respect to conventional pulse oximetry, our approach provides more-comprehensive information about the tissue oxygenation level, it can provide the local SaO 2 of the brain, and it can be applied over the full range of SaO 2 values.
At a recent conference (BiOS '99 Biomedical Optics Symposium, San Jose, California, January 23-29,
